Situs ambiguus

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:157769Q89.3
Who is this for?
Show terms as
26Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Situs ambiguus, also known as heterotaxy or heterotaxy syndrome, is a rare congenital condition characterized by an abnormal arrangement of the internal organs across the left-right axis of the body that is neither the normal arrangement (situs solitus) nor a complete mirror-image reversal (situs inversus). Instead, the organs are positioned in an indeterminate or discordant pattern. The condition primarily affects the thoracic and abdominal organs, including the heart, lungs, spleen, liver, stomach, and intestines. Situs ambiguus is broadly categorized into two subtypes: left isomerism (also called polysplenia syndrome), in which bilateral left-sidedness features predominate, and right isomerism (also called asplenia syndrome), in which bilateral right-sidedness features predominate. Congenital heart defects are the most clinically significant feature and are present in the vast majority of affected individuals. These may include atrioventricular septal defects, transposition of the great arteries, double outlet right ventricle, total anomalous pulmonary venous return, and abnormalities of the cardiac conduction system. Patients with right isomerism frequently have asplenia (absence of the spleen), which leads to increased susceptibility to life-threatening bacterial infections, particularly from encapsulated organisms. Patients with left isomerism may have polysplenia (multiple small spleens) with variable splenic function. Other associated features include intestinal malrotation, biliary atresia, and abnormalities of the inferior vena cava. Management of situs ambiguus is multidisciplinary and depends on the specific constellation of anomalies present. Treatment of complex congenital heart disease often requires staged surgical interventions, which may include palliative procedures or corrective open-heart surgery. Patients with asplenia require lifelong antibiotic prophylaxis and vaccination against encapsulated bacteria to prevent overwhelming sepsis. Intestinal malrotation may require surgical correction if it leads to volvulus. Prognosis varies widely depending on the severity of the cardiac defects and associated anomalies, with right isomerism generally carrying a more guarded prognosis than left isomerism. Genetic counseling is recommended, as the condition can be caused by mutations in several genes involved in left-right patterning, including ZIC3, NODAL, CFC1, ACVR2B, LEFTY2, GDF1, and others.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Situs ambiguus.

View clinical trials →

No actively recruiting trials found for Situs ambiguus at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Situs ambiguus community →

Specialists

Showing 25 of 26View all specialists →
HM
Heymut Omran, MD
Specialist
PI on 1 active trial
MM
Margaret W Leigh, MD
CHAPEL HILL, NC
Specialist
PI on 1 active trial
MM
Margaret Rosenfeld, MD
EVANSTON, IL
Specialist
PI on 1 active trial
SP
Serge AMSELEM, MD PhD
Specialist
PI on 1 active trial
MM
Michael R Knowles, MD
CHAPEL HILL, NC
Specialist
PI on 1 active trial
MM
Michael Knowles, MD
CHAPEL HILL, NC
Specialist
PI on 2 active trials
KM
Kenneth Olivier, MD, MPH
ROCHESTER, MN
Specialist
PI on 1 active trial
KS
Kim G Nielsen, Dr Med Sci
Specialist
PI on 1 active trial
LM
Lindsay Ryerson, MD
ANN ARBOR, MI
Specialist
PI on 1 active trial1 Situs ambiguus publication
MM
Myrofora Goutaki, MD-PhD
Specialist
PI on 1 active trial
KM
Kenneth R. Olivier, MD, MPH
ROCHESTER, MN
Specialist
PI on 1 active trial
SP
Stephanie M. Ware, MD, PhD
Specialist
PI on 1 active trial
HD
Hayriye Ugur Ozcelik, Prof. Dr.
Specialist
PI on 1 active trial
TB
Terence Prendiville, MB BCh BAO
Specialist
PI on 1 active trial3 Situs ambiguus publications
SM
Stephanie Davis, MD
Specialist
PI on 2 active trials
MM
Michael Loebinger, MD
Specialist
PI on 1 active trial
SD
Stephanie Davis
Specialist
PI on 1 active trial56 Situs ambiguus publications
AP
Alan L. Ho, MD, PhD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Situs ambiguus.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Situs ambiguusForum →

No community posts yet. Be the first to share your experience with Situs ambiguus.

Start the conversation →

Latest news about Situs ambiguus

No recent news articles for Situs ambiguus.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Situs ambiguus

What is Situs ambiguus?

Situs ambiguus, also known as heterotaxy or heterotaxy syndrome, is a rare congenital condition characterized by an abnormal arrangement of the internal organs across the left-right axis of the body that is neither the normal arrangement (situs solitus) nor a complete mirror-image reversal (situs inversus). Instead, the organs are positioned in an indeterminate or discordant pattern. The condition primarily affects the thoracic and abdominal organs, including the heart, lungs, spleen, liver, stomach, and intestines. Situs ambiguus is broadly categorized into two subtypes: left isomerism (also

At what age does Situs ambiguus typically begin?

Typical onset of Situs ambiguus is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Situs ambiguus?

25 specialists and care centers treating Situs ambiguus are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.